PMID- 24760992 OWN - NLM STAT- MEDLINE DCOM- 20140820 LR - 20171116 IS - 1522-1555 (Electronic) IS - 0193-1849 (Linking) VI - 306 IP - 12 DP - 2014 Jun 15 TI - Mice lacking NOX2 are hyperphagic and store fat preferentially in the liver. PG - E1341-53 LID - 10.1152/ajpendo.00089.2014 [doi] AB - Chronic low-grade inflammation is an important contributor to the development of insulin resistance, a hallmark of type 2 diabetes mellitus (T2DM). Obesity and high-fat feeding lead to infiltration of immune cells into metabolic tissues, promoting inflammation and insulin resistance. We hypothesized that macrophages from mice lacking NOX2 (Cybb), an essential component of the NADPH oxidase complex highly expressed in immune cells and associated with their inflammatory response, would be less inflammatory and that these mice would be protected from the development of high-fat-induced insulin resistance. Bone marrow-derived macrophages from NOX2 knockout (NOX2-KO) mice expressed lower levels of inflammatory markers (Nos2, Il6); however, NOX2-KO mice were hyperphagic and gained more weight than wild-type (WT) mice when fed either a chow or a high-fat (HF) diet. Surprisingly, NOX2-KO mice stored less lipid in epididymal white adipose tissue but more lipid in liver and had higher indexes of liver inflammation and macrophage infiltration than WT mice. Contrary to our hypothesis, HF-fed NOX2-KO mice were hyperinsulinemic and more insulin resistant than HF-fed WT mice, likely as a result of their higher hepatic steatosis and inflammation. In summary, NOX2 depletion promoted hyperphagia, hepatic steatosis, and inflammation with either normal or high-fat feeding, exacerbating insulin resistance. We propose that NOX2 participates in food intake control and lipid distribution in mice. CI - Copyright (c) 2014 the American Physiological Society. FAU - Costford, Sheila R AU - Costford SR AD - The Hospital for Sick Children, Toronto, Ontario, Canada; FAU - Castro-Alves, Jason AU - Castro-Alves J AD - The Hospital for Sick Children, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. FAU - Chan, Kenny L AU - Chan KL AD - The Hospital for Sick Children, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. FAU - Bailey, Liane J AU - Bailey LJ AD - The Hospital for Sick Children, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. FAU - Woo, Minna AU - Woo M AD - Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. FAU - Belsham, Denise D AU - Belsham DD AD - University of Toronto, Toronto, Ontario, Canada. FAU - Brumell, John H AU - Brumell JH AD - The Hospital for Sick Children, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada. FAU - Klip, Amira AU - Klip A AD - The Hospital for Sick Children, Toronto, Ontario, Canada; University of Toronto, Toronto, Ontario, Canada amira@sickkids.ca. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140422 PL - United States TA - Am J Physiol Endocrinol Metab JT - American journal of physiology. Endocrinology and metabolism JID - 100901226 RN - 0 (Membrane Glycoproteins) RN - EC 1.6.3.- (Cybb protein, mouse) RN - EC 1.6.3.- (NADPH Oxidase 2) RN - EC 1.6.3.- (NADPH Oxidases) SB - IM MH - Adipose Tissue, White/immunology/metabolism/pathology MH - Animals MH - *Appetite Regulation MH - Appetitive Behavior MH - Behavior, Animal MH - Cells, Cultured MH - Diabetes Mellitus, Type 2/complications/etiology MH - Diet, High-Fat/adverse effects MH - Fatty Liver/complications/*etiology MH - Hyperphagia/immunology/*metabolism/pathology/physiopathology MH - *Insulin Resistance MH - *Lipid Metabolism MH - Liver/immunology/*metabolism/pathology MH - Macrophages/immunology/metabolism/pathology MH - Male MH - Membrane Glycoproteins/genetics/*metabolism MH - Mice MH - Mice, 129 Strain MH - Mice, Inbred C57BL MH - Mice, Knockout MH - NADPH Oxidase 2 MH - NADPH Oxidases/genetics/*metabolism MH - Non-alcoholic Fatty Liver Disease MH - Obesity/complications/etiology OTO - NOTNLM OT - NOX2 OT - fatty liver OT - hyperphagia OT - insulin resistance EDAT- 2014/04/25 06:00 MHDA- 2014/08/21 06:00 CRDT- 2014/04/25 06:00 PHST- 2014/04/25 06:00 [entrez] PHST- 2014/04/25 06:00 [pubmed] PHST- 2014/08/21 06:00 [medline] AID - ajpendo.00089.2014 [pii] AID - 10.1152/ajpendo.00089.2014 [doi] PST - ppublish SO - Am J Physiol Endocrinol Metab. 2014 Jun 15;306(12):E1341-53. doi: 10.1152/ajpendo.00089.2014. Epub 2014 Apr 22.